66 related articles for article (PubMed ID: 20509312)
1. The pharmacological activity of some new fluorescent small molecule histamine H2 receptor (H2-R) ligands, derived from aminopotentidine and squaramide, in the GTPase assay.
Petrache G; Pavelescu MD
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):255-9. PubMed ID: 20509312
[TBL] [Abstract][Full Text] [Related]
2. The expanded pharmacological profile of histamine H2 receptor (H2R) species isoforms with respect to the interaction with new squaramide H2R ligands, in the GTP-ASE assay.
Petrache G; Pavelescu MD
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):915-20. PubMed ID: 20191855
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological characterization of novel fluorescent histamine H2-receptor ligands derived from aminopotentidine.
Xie SX; Petrache G; Schneider E; Ye QZ; Bernhardt G; Seifert R; Buschauer A
Bioorg Med Chem Lett; 2006 Aug; 16(15):3886-90. PubMed ID: 16730977
[TBL] [Abstract][Full Text] [Related]
4. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
[TBL] [Abstract][Full Text] [Related]
6. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
[TBL] [Abstract][Full Text] [Related]
7. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
[TBL] [Abstract][Full Text] [Related]
8. Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.
Kelley MT; Bürckstümmer T; Wenzel-Seifert K; Dove S; Buschauer A; Seifert R
Mol Pharmacol; 2001 Dec; 60(6):1210-25. PubMed ID: 11723228
[TBL] [Abstract][Full Text] [Related]
9. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
[TBL] [Abstract][Full Text] [Related]
10. [(3) H]UR-DE257: development of a tritium-labeled squaramide-type selective histamine H2 receptor antagonist.
Baumeister P; Erdmann D; Biselli S; Kagermeier N; Elz S; Bernhardt G; Buschauer A
ChemMedChem; 2015 Jan; 10(1):83-93. PubMed ID: 25320025
[TBL] [Abstract][Full Text] [Related]
11. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
[TBL] [Abstract][Full Text] [Related]
12. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists.
Birnkammer T; Spickenreither A; Brunskole I; Lopuch M; Kagermeier N; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
J Med Chem; 2012 Feb; 55(3):1147-60. PubMed ID: 22216892
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization.
Malan SF; van Marle A; Menge WM; Zuliani V; Hoffman M; Timmerman H; Leurs R
Bioorg Med Chem; 2004 Dec; 12(24):6495-503. PubMed ID: 15556766
[TBL] [Abstract][Full Text] [Related]
14. N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.
Kraus A; Ghorai P; Birnkammer T; Schnell D; Elz S; Seifert R; Dove S; Bernhardt G; Buschauer A
ChemMedChem; 2009 Feb; 4(2):232-40. PubMed ID: 19072936
[TBL] [Abstract][Full Text] [Related]
15. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists.
Ghorai P; Kraus A; Keller M; Götte C; Igel P; Schneider E; Schnell D; Bernhardt G; Dove S; Zabel M; Elz S; Seifert R; Buschauer A
J Med Chem; 2008 Nov; 51(22):7193-204. PubMed ID: 18950149
[TBL] [Abstract][Full Text] [Related]
16. Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.
Ghorai P; Kraus A; Birnkammer T; Geyer R; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
Bioorg Med Chem Lett; 2010 May; 20(10):3173-6. PubMed ID: 20409707
[TBL] [Abstract][Full Text] [Related]
17. Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cells.
Beukers MW; Klaassen CH; De Grip WJ; Verzijl D; Timmerman H; Leurs R
Br J Pharmacol; 1997 Nov; 122(5):867-74. PubMed ID: 9384502
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H
Biselli S; Bresinsky M; Tropmann K; Forster L; Honisch C; Buschauer A; Bernhardt G; Pockes S
Eur J Med Chem; 2021 Mar; 214():113190. PubMed ID: 33548637
[TBL] [Abstract][Full Text] [Related]
19. Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha).
Wenzel-Seifert K; Kelley MT; Buschauer A; Seifert R
J Pharmacol Exp Ther; 2001 Dec; 299(3):1013-20. PubMed ID: 11714890
[TBL] [Abstract][Full Text] [Related]
20. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
